Published in J Transplant on February 29, 2012
Strategies to optimize the use of marginal donors in liver transplantation. World J Hepatol (2015) 0.95
Autophagy and liver ischemia-reperfusion injury. Biomed Res Int (2015) 0.88
Sanguineous normothermic machine perfusion improves hemodynamics and biliary epithelial regeneration in donation after cardiac death porcine livers. Liver Transpl (2014) 0.82
Aetiology and risk factors of ischaemic cholangiopathy after liver transplantation. World J Gastroenterol (2014) 0.80
Role of matrix metalloproteinases in cholestasis and hepatic ischemia/reperfusion injury: A review. World J Gastroenterol (2015) 0.78
Biliary complications after pediatric liver transplantation: Risk factors, diagnosis and management. World J Hepatol (2015) 0.78
Sequential vs simultaneous revascularization in patients undergoing liver transplantation: A meta-analysis. World J Gastroenterol (2015) 0.77
Delayed rearterialization unlikely leads to nonanastomotic stricture but causes temporary injury on bile duct after liver transplantation. Transpl Int (2014) 0.77
Warm ischemia may damage peribiliary vascular plexus during DCD liver transplantation. Int J Clin Exp Med (2015) 0.75
Biliary Cast Syndrome: Hepatic Artery Resistance Index, Pathological Changes, Morphology and Endoscopic Therapy. Chin Med J (Engl) (2015) 0.75
Temporary abdominal closure and delayed biliary reconstruction due to massive bleeding in patients undergoing liver transplantation: an old trick in a new indication. J Hepatobiliary Pancreat Sci (2016) 0.75
Secondary sclerosing cholangitis in a critically ill patient. Quant Imaging Med Surg (2016) 0.75
Study of relationship between the blood supply of the extrahepatic bile duct and duct supply branches from gastroduodenal artery on imaging and anatomy. Chin Med J (Engl) (2015) 0.75
Sustained Isoprostane E2 Elevation, Inflammation and Fibrosis after Acute Ischaemia-Reperfusion Injury Are Reduced by Pregnane X Receptor Activation. PLoS One (2015) 0.75
Liver Preservation by Aortic Perfusion Alone Compared With Preservation by Aortic Perfusion and Additional Arterial Ex Situ Back-Table Perfusion With Histidine-Tryptophan-Ketoglutarate Solution: A Prospective, Randomized, Controlled, Multicenter Study. Transplant Direct (2017) 0.75
Elevated Preoperative Serum Bilirubin Improves Reperfusion Injury and Survival Postliver Transplantation. Transplant Direct (2017) 0.75
Donor Diabetes and Prolonged Cold Ischemia Time Synergistically Increase the Risk of Graft Failure After Liver Transplantation. Transplant Direct (2017) 0.75
Effects of cytochalasin and phalloidin on actin. J Cell Biol (1987) 10.32
Characteristics associated with liver graft failure: the concept of a donor risk index. Am J Transplant (2006) 8.03
Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors. Science (1997) 6.82
Mechanisms of hepatotoxicity. Toxicol Sci (2002) 4.13
Clinical presentation of hepatic artery thrombosis after liver transplantation in the cyclosporine era. Transplantation (1985) 3.91
Hepatic ischemia/reperfusion injury--a fresh look. Exp Mol Pathol (2003) 2.81
Infections with cytomegalovirus and other herpesviruses in 121 liver transplant recipients: transmission by donated organ and the effect of OKT3 antibodies. J Infect Dis (1988) 2.76
Molecular pathogenesis of cholestasis. N Engl J Med (1998) 2.68
A new look at the arterial supply of the bile duct in man and its surgical implications. Br J Surg (1979) 2.66
The biochemistry of programmed cell death. FASEB J (1995) 2.63
Liver transplantation from controlled non-heart-beating donors: an increased incidence of biliary complications. Transplantation (2003) 2.63
The cholangiopathies: disorders of biliary epithelia. Gastroenterology (2004) 2.38
Identification of novel, functional genetic variants in the human matrix metalloproteinase-2 gene: role of Sp1 in allele-specific transcriptional regulation. J Biol Chem (2000) 2.35
Toxic bile salts induce rodent hepatocyte apoptosis via direct activation of Fas. J Clin Invest (1999) 2.32
Na+,K(+)-ATPase. J Biol Chem (1994) 2.23
Risk factors for primary dysfunction after liver transplantation--a multivariate analysis. Transplantation (1993) 2.20
Preservation and reperfusion injuries in liver allografts. An overview and synthesis of current studies. Transplantation (1992) 2.03
Survival following liver transplantation from non-heart-beating donors. Ann Surg (2004) 1.96
Lipocytes from normal rat liver release a neutral metalloproteinase that degrades basement membrane (type IV) collagen. J Clin Invest (1989) 1.95
Cytokines and the liver. J Hepatol (1997) 1.92
Sinusoidal lining cell damage: the critical injury in cold preservation of liver allografts in the rat. Transplantation (1988) 1.78
Incidence of and risk factors for ischemic-type biliary lesions following orthotopic liver transplantation. Transpl Int (2009) 1.77
Report of the Paris consensus meeting on expanded criteria donors in liver transplantation. Liver Transpl (2008) 1.75
Mechanisms and regulation of bile secretion. Hepatology (1991) 1.74
Liver ischemia and reperfusion injury: new insights into mechanisms of innate-adaptive immune-mediated tissue inflammation. Am J Transplant (2011) 1.71
CCR5 signaling suppresses inflammation and reduces adverse remodeling of the infarcted heart, mediating recruitment of regulatory T cells. Am J Pathol (2010) 1.69
Donation after cardiac death: the University of Wisconsin experience with liver transplantation. Ann Surg (2005) 1.67
Donation after cardiac death as a strategy to increase deceased donor liver availability. Ann Surg (2006) 1.66
Ischemic cholangitis in hepatic allografts. Mayo Clin Proc (1992) 1.66
ABO-incompatible liver transplantation with no immunological graft losses using total plasma exchange, splenectomy, and quadruple immunosuppression: evidence for accommodation. Liver Transpl (2003) 1.65
Liver transplantation using donation after cardiac death donors: long-term follow-up from a single center. Am J Transplant (2009) 1.59
A simple modification in operative technique can reduce the incidence of nonanastomotic biliary strictures after orthotopic liver transplantation. Hepatology (1995) 1.59
Comparison of histidine-tryptophan-ketoglutarate solution (HTK) and University of Wisconsin solution (UW) in adult liver transplantation. Liver Transpl (2006) 1.57
Electron microscopic studies of normal and proliferated bile ductules. Am J Pathol (1961) 1.56
Ursodeoxycholic acid may inhibit deoxycholic acid-induced apoptosis by modulating mitochondrial transmembrane potential and reactive oxygen species production. Mol Med (1998) 1.55
Protective role of tauroursodeoxycholate during harvesting and cold storage of human liver: a pilot study in transplant recipients. Transplantation (2001) 1.53
Generation of hydroperoxides in isolated rat hepatocytes and hepatic mitochondria exposed to hydrophobic bile acids. Gastroenterology (1995) 1.52
Ischemic-type biliary complications after orthotopic liver transplantation. Hepatology (1992) 1.46
The delay of rearterialization after initial portal reperfusion in living donor liver transplantation significantly determines the development of microvascular graft dysfunction. J Hepatol (2004) 1.46
Risk factors for and clinical course of non-anastomotic biliary strictures after liver transplantation. Am J Transplant (2003) 1.46
The biopsied donor liver: incorporating macrosteatosis into high-risk donor assessment. Liver Transpl (2010) 1.44
Grade of deceased donor liver macrovesicular steatosis impacts graft and recipient outcomes more than the Donor Risk Index. J Gastroenterol Hepatol (2012) 1.44
Blood supply of the right and left hepatic ducts. Br J Surg (1998) 1.43
Mechanisms of reperfusion injury after warm ischemia of the liver. J Hepatobiliary Pancreat Surg (1998) 1.42
Analysis of chronic rejection and obliterative arteriopathy. Possible contributions of donor antigen-presenting cells and lymphatic disruption. Am J Pathol (1997) 1.41
A caspase inhibitor fully protects rats against lethal normothermic liver ischemia by inhibition of liver apoptosis. FASEB J (1999) 1.41
The pathobiology of biliary epithelia. Hepatology (2002) 1.40
The impact of ischemic cholangiopathy in liver transplantation using donors after cardiac death: the untold story. Surgery (2009) 1.39
The significance of parenchymal changes of acute cellular rejection in predicting chronic liver graft rejection. Transplantation (2002) 1.38
Acute fatty liver of pregnancy and the microvesicular fat diseases. Gut (1983) 1.37
Ischemic cholangiopathy following liver transplantation from donation after cardiac death donors. Liver Transpl (2008) 1.36
PPAR: a mediator of peroxisome proliferator action. Mutat Res (1995) 1.36
Biliary tract complications after liver transplantation: a review. Dig Surg (2008) 1.36
Reactive oxygen and ischemia/reperfusion injury of the liver. Chem Biol Interact (1991) 1.31
Biliary complications following liver transplantation in the model for end-stage liver disease era: effect of donor, recipient, and technical factors. Liver Transpl (2008) 1.30
A histometric analysis of chronically rejected human liver allografts: insights into the mechanisms of bile duct loss: direct immunologic and ischemic factors. Hepatology (1989) 1.30
Liver transplantation across ABO blood group barriers. Lancet (1990) 1.29
Matrix metalloproteinase inhibition protects rat livers from prolonged cold ischemia-warm reperfusion injury. Hepatology (2008) 1.27
Tissue distribution of the death ligand TRAIL and its receptors. J Histochem Cytochem (2004) 1.27
Biliary strictures complicating liver transplantation. Incidence, pathogenesis, management, and outcome. Ann Surg (1992) 1.23
Caspase 9-dependent killing of hepatic stellate cells by activated Kupffer cells. Gastroenterology (2002) 1.23
Use of fatty donor liver is associated with diminished early patient and graft survival. Transplantation (1996) 1.22
Effect of ischemia-reperfusion injury on the microcirculation of the steatotic liver of the Zucker rat. Transplantation (2001) 1.21
Classification and prognosis of intrahepatic biliary stricture after liver transplantation. Liver Transpl (2007) 1.21
Histopathology of early and late human hepatic allograft rejection: evidence of progressive destruction of interlobular bile ducts. Hepatology (1985) 1.21
Evidence of a role for matrix metalloproteinases in cold preservation injury of the liver in humans and in the rat. Hepatology (1997) 1.19
MMP-2: expression, activation and inhibition. Enzyme Protein (1996) 1.19
High or low hepaticojejunostomy for bile duct strictures? Surgery (1990) 1.19
Linked common polymorphisms in the gelatinase a promoter are associated with diminished transcriptional response to estrogen and genetic fitness. J Biol Chem (2003) 1.19
Diagnostic features and clinical outcome of ischemic-type biliary complications after liver transplantation. Hepatology (1993) 1.18
Functional heterogeneity of the intrahepatic biliary epithelium. Hepatology (2000) 1.17
Causes and consequences of ischemic-type biliary lesions after liver transplantation. J Hepatobiliary Pancreat Surg (2006) 1.17
The biliary HCO(3)(-) umbrella: a unifying hypothesis on pathogenetic and therapeutic aspects of fibrosing cholangiopathies. Hepatology (2010) 1.16
Matrix metalloproteinase 2 genotype is associated with nonanastomotic biliary strictures after orthotopic liver transplantation. Liver Int (2011) 1.15
Hepatic microcirculation and peribiliary plexus in experimental biliary cirrhosis: a morphological study. Gastroenterology (1996) 1.14
Nonanastomotic biliary strictures after liver transplantation, part 2: Management, outcome, and risk factors for disease progression. Liver Transpl (2007) 1.12
Evidence of preservation injury to bile ducts by bile salts in the pig and its prevention by infusions of hydrophilic bile salts. Hepatology (1995) 1.12
The greater vulnerability of bile duct cells to reoxygenation injury than to anoxia. Implications for the pathogenesis of biliary strictures after liver transplantation. Transplantation (1993) 1.11
Role of gender and race mismatch and graft failure in patients undergoing liver transplantation. Liver Transpl (2002) 1.11
Ischemic cholangiopathy after controlled donation after cardiac death liver transplantation: a meta-analysis. Ann Surg (2011) 1.11
Glutathione as a primary osmotic driving force in hepatic bile formation. Am J Physiol (1992) 1.11
Increased bile duct complications in liver transplantation across the ABO barrier. Ann Surg (1993) 1.11
The blood supply of the biliary ductal system and its relevance to vasculobiliary injuries following cholecystectomy. Aust N Z J Surg (1999) 1.11
Expression profiles of MUC mucins and trefoil factor family (TFF) peptides in the intrahepatic biliary system: physiological distribution and pathological significance. Prog Histochem Cytochem (2007) 1.10
Blood group antigens in the intrahepatic biliary tree. I. Distribution in the normal liver. J Hepatol (1988) 1.09
Peroxisome proliferator-activated receptor-gamma protects against hepatic ischemia/reperfusion injury in mice. Hepatology (2008) 1.09
Cytotoxicity of bile salts against biliary epithelium: a study in isolated bile ductule fragments and isolated perfused rat liver. Hepatology (1997) 1.09
The combination of primary sclerosing cholangitis and CCR5-Δ32 in recipients is strongly associated with the development of nonanastomotic biliary strictures after liver transplantation. Liver Int (2010) 1.08
Liver transplant using donors after unexpected cardiac death: novel preservation protocol and acceptance criteria. Am J Transplant (2007) 1.08
Evidence that portal tract microvascular destruction precedes bile duct loss in human liver allograft rejection. Transplantation (1993) 1.08
Mechanism of cholestasis. 5. Bile acids in normal rat livers and in those after bile duct ligation. Gastroenterology (1972) 1.06
Age-dependent responses to hepatic ischemia/reperfusion injury. Shock (2005) 1.06
Glutathione depletion is associated with decreased Bcl-2 expression and increased apoptosis in cholangiocytes. Am J Physiol (1998) 1.05
Role of oxygen availability in CFTR expression and function. Am J Respir Cell Mol Biol (2008) 1.05
Preliminary study of the anatomy of the venous drainage of the intrahepatic and extrahepatic bile ducts and its relevance to the practice of hepatobiliary surgery. ANZ J Surg (2001) 1.04
Nonanastomotic biliary strictures after liver transplantation, part 1: Radiological features and risk factors for early vs. late presentation. Liver Transpl (2007) 1.03
Anatomy of the human biliary system studied by quantitative computer-aided three-dimensional imaging techniques. Hepatology (1998) 1.03
Prevention of ischemic-type biliary lesions by arterial back-table pressure perfusion. Liver Transpl (2003) 1.03
Preservation methods for kidney and liver. Organogenesis (2009) 1.03
Histidine-tryptophan-ketoglutarate solution vs. University of Wisconsin solution for liver transplantation: a systematic review. Liver Transpl (2007) 1.01
Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. Lancet Oncol (2008) 5.93
Increased adipose tissue expression of hepcidin in severe obesity is independent from diabetes and NASH. Gastroenterology (2006) 3.09
Regular coffee but not espresso drinking is protective against fibrosis in a cohort mainly composed of morbidly obese European women with NAFLD undergoing bariatric surgery. J Hepatol (2012) 2.39
Liver transplantation for hepatocellular carcinoma: a model including α-fetoprotein improves the performance of Milan criteria. Gastroenterology (2012) 2.01
Positioning trocars for performing sleeve gastrectomy. Points of controversy. Obes Surg (2015) 1.90
Impact of UCSF criteria according to pre- and post-OLT tumor features: analysis of 479 patients listed for HCC with a short waiting time. Liver Transpl (2006) 1.86
Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma: A Randomized, Multicenter, Open-Label Phase 3 Trial. Transplantation (2016) 1.59
Role of immunosuppression and tumor differentiation in predicting recurrence after liver transplantation for hepatocellular carcinoma: a multicenter study of 412 patients. World J Gastroenterol (2006) 1.58
C-reactive protein levels in relation to various features of non-alcoholic fatty liver disease among obese patients. J Hepatol (2011) 1.54
Gastric pouch resizing for Roux-en-Y gastric bypass failure in patients with a dilated pouch. Surg Obes Relat Dis (2012) 1.49
KRAS and BRAF mutational status in primary colorectal tumors and related metastatic sites: biological and clinical implications. Ann Surg Oncol (2010) 1.48
The pig as a preclinical model for intestinal ischemia-reperfusion and transplantation studies. J Surg Res (2012) 1.44
Hepatic expression patterns of inflammatory and immune response genes associated with obesity and NASH in morbidly obese patients. PLoS One (2010) 1.44
Identification of adipose tissue dendritic cells correlated with obesity-associated insulin-resistance and inducing Th17 responses in mice and patients. Diabetes (2012) 1.42
The inflammatory C-reactive protein is increased in both liver and adipose tissue in severely obese patients independently from metabolic syndrome, Type 2 diabetes, and NASH. Am J Gastroenterol (2006) 1.42
Patients with acute liver failure listed for superurgent liver transplantation in France: reevaluation of the Clichy-Villejuif criteria. Liver Transpl (2015) 1.38
Internal hernia after laparoscopic Roux-en-Y gastric bypass for morbid obesity. Obes Surg (2006) 1.33
Elevated expression of osteopontin may be related to adipose tissue macrophage accumulation and liver steatosis in morbid obesity. Diabetes (2008) 1.30
Impact of pretransplantation transarterial chemoembolization on survival and recurrence after liver transplantation for hepatocellular carcinoma. Liver Transpl (2005) 1.28
Matrix metalloproteinase inhibition protects rat livers from prolonged cold ischemia-warm reperfusion injury. Hepatology (2008) 1.27
The role of clips in preventing migration of fully covered metallic esophageal stents: a pilot comparative study. Surg Endosc (2011) 1.26
Laparoscopic repair of intrathoracic mesenterioaxial volvulus of the stomach in an adult: report of a case. Surg Today (2003) 1.23
Laparoscopic sleeve gastrectomy for morbid obesity. World J Gastroenterol (2008) 1.19
Palliative portal vein stent placement in malignant and symptomatic extrinsic portal vein stenosis or occlusion. Cardiovasc Intervent Radiol (2008) 1.19
Revised sleeve gastrectomy: another option for weight loss failure after sleeve gastrectomy. Surg Endosc (2013) 1.11
Assessment of different bariatric surgeries in the treatment of obesity and insulin resistance in mice. Ann Surg (2014) 1.07
Percutaneous jejunostomy and stent placement for treatment of malignant Roux-en-Y obstruction: a case report. Clin Imaging (2006) 1.06
A prospective randomised, open-labeled, trial comparing sirolimus-containing versus mTOR-inhibitor-free immunosuppression in patients undergoing liver transplantation for hepatocellular carcinoma. BMC Cancer (2010) 1.06
Leiomyosarcoma of the ovarian vein: report of a case. Int Surg (2003) 1.04
Regulation of Bcl-2 and Bcl-xL anti-apoptotic protein expression by nuclear receptor PXR in primary cultures of human and rat hepatocytes. Biochim Biophys Acta (2005) 1.02
Single incision laparoscopic surgery cholecystectomy: a preliminary experience. Surg Laparosc Endosc Percutan Tech (2010) 1.01
Internal hernia as a complication of laparoscopic Roux-en-Y gastric bypass. Obes Surg (2007) 0.96
Cetuximab shows activity in colorectal cancer patients with tumors for which FISH analysis does not detect an increase in EGFR gene copy number. Ann Surg Oncol (2007) 0.95
Laparoscopic Roux-en-Y gastric bypass with the absorbable bidirectional monofilament barbed suture Stratafix®: the hand-sewn technique. Obes Surg (2015) 0.94
Re-sleeve gastrectomy for failed laparoscopic sleeve gastrectomy: a feasibility study. Obes Surg (2011) 0.94
Laparoscopic sleeve gastrectomy as revisional procedure for failed gastric banding and vertical banded gastroplasty. Obes Surg (2009) 0.92
Laparoscopic Conversion of a Sleeve Gastrectomy to the Roux-en-Y Gastric Bypass. Obes Surg (2015) 0.92
Agenesis of the right liver: a difficult laparoscopic cholecystectomy. J Laparoendosc Adv Surg Tech A (2005) 0.92
Bariatric surgery can correct iron depletion in morbidly obese women: a link with chronic inflammation. Obes Surg (2008) 0.91
Atypical MRI features of a biliary cystadenoma revealed by jaundice. Clin Imaging (2006) 0.90
Rab4b is a small GTPase involved in the control of the glucose transporter GLUT4 localization in adipocyte. PLoS One (2009) 0.90
Impact of laparoscopic Roux-en-Y gastric bypass on metabolic syndrome, inflammation, and insulin resistance in super versus morbidly obese women. Obes Surg (2008) 0.89
Rat liver injury after normothermic ischemia is prevented by a phosphinic matrix metalloproteinase inhibitor. FASEB J (2001) 0.89
Iatrogenic injury of the intrathoracic esophagus sustained during a gastric banding procedure. Obes Surg (2008) 0.89
Effect of polyethylene glycol in pig intestinal allotransplantation without immunosuppression. J Surg Res (2011) 0.87
Therapeutic laparoscopy for blunt abdominal trauma with bowel injuries. J Laparoendosc Adv Surg Tech A (2003) 0.87
Laparoscopic conversion of vertical banded gastroplasty (Mason MacLean) into Roux-en-Y gastric bypass. Obes Surg (2007) 0.85
Warm ischemia-reperfusion injury is decreased by tacrolimus in steatotic rat liver. Liver Transpl (2006) 0.85
Gastric necrosis: a rare complication of gastric banding. Obes Surg (2005) 0.85
Enigma interacts with adaptor protein with PH and SH2 domains to control insulin-induced actin cytoskeleton remodeling and glucose transporter 4 translocation. Mol Endocrinol (2006) 0.85
Laparoscopic entry techniques in obese patient: veress needle, direct trocar insertion or open entry technique? Obes Surg (2014) 0.84
Bariatric surgery and liver transplantation: a systematic review a new frontier for bariatric surgery. Obes Surg (2015) 0.84
Use of the PlasmaJet System in patients undergoing abdominal lipectomy following massive weight loss: a randomized controlled trial. Obes Surg (2010) 0.84
Hypoxia-reoxygenation-induced chemokine transcription is not prevented by preconditioning or intermittent hypoxia, in mice hepatocytes. Transpl Int (2005) 0.84
Hemojuvelin: a new link between obesity and iron homeostasis. Obesity (Silver Spring) (2011) 0.84
Pentoxifylline inhibits liver expression of tumor necrosis factor alpha mRNA following normothermic ischemia-reperfusion. HPB (Oxford) (2007) 0.83
Body composition, anthropometrics, energy expenditure, systemic inflammation, in premenopausal women 1 year after laparoscopic Roux-en-Y gastric bypass. Surg Endosc (2013) 0.83
Wernicke's encephalopathy after laparoscopic Roux-en-Y gastric bypass: a misdiagnosed complication. Obes Surg (2010) 0.83
Use of PlasmaJet system in patients undergoing abdominal lipectomy following massive weight loss resulting from bariatric surgery: early experience. Obes Surg (2006) 0.82
[Multiple focal nodular hyperplasia of the liver associated with congenital absence of the portal vein]. Gastroenterol Clin Biol (2006) 0.82
Fas ligand expression following normothermic liver ischemia-reperfusion. J Surg Res (2005) 0.81
Hiatal hernia of the Roux-en-Y gastric bypass pouch 8 years after surgery. Obes Surg (2014) 0.81
Comparison of two techniques of transarterial chemoembolization before liver transplantation for hepatocellular carcinoma: a case-control study. Liver Transpl (2007) 0.81
Impact of tumour differentiation to select patients before liver transplantation for hepatocellular carcinoma. Liver Int (2011) 0.81
[Hemobilia due to pseudoaneurysm of the right hepatic artery following laparoscopic cholecystectomy]. Gastroenterol Clin Biol (2003) 0.80
A Randomized Multicenter Study Comparing a Tacrolimus-Based Protocol with and without Steroids in HCV-Positive Liver Allograft Recipients. J Transplant (2012) 0.80
MR cholangiopancreatography features of the biliary tree after liver transplantation. AJR Am J Roentgenol (2008) 0.80
Effects of sleeve gastrectomy in high fat diet-induced obese mice: respective role of reduced caloric intake, white adipose tissue inflammation and changes in adipose tissue and ectopic fat depots. Surg Endosc (2013) 0.80
Gefitinib-trastuzumab combination on hormone-refractory prostate cancer xenograft. Eur J Cancer (2005) 0.80
Rat liver ischemia-reperfusion-induced apoptosis and necrosis are decreased by FK506 pretreatment. Eur J Pharmacol (2003) 0.79
Small bowel diverticulitis of the Roux loop after gastric bypass. Obes Surg (2006) 0.79
Recurrence after liver transplantation for hepatocellular carcinoma according to up-to-seven criteria. Hepatogastroenterology (2013) 0.79
Male microchimerism at high levels in peripheral blood mononuclear cells from women with end stage renal disease before kidney transplantation. PLoS One (2012) 0.79
Preoperative 4-week supplementation with omega-3 polyunsaturated fatty acids reduces liver volume and facilitates bariatric surgery in morbidly obese patients. Obes Surg (2013) 0.78
Tyrosine phosphorylation of insulin receptor substrates during ischemia/reperfusion-induced apoptosis in rat liver. Langenbecks Arch Surg (2008) 0.78
Two-step laparoscopic duodenal switch for superobesity: a feasibility study. Surg Endosc (2009) 0.78
Assessing renal function with daclizumab induction and delayed tacrolimus introduction in liver transplant recipients. Transplantation (2010) 0.78
Internal hernias and nonclosure of mesenteric defects during laparoscopic Roux-en-Y gastric bypass. Obes Surg (2010) 0.78
Effect of caspase inhibition on thymic apoptosis in hemorrhagic shock. J Invest Surg (2007) 0.77
Metastatic hepatic epithelioid hemangio-endothelioma: long-term response to sunitinib malate. Oncol Res Treat (2014) 0.77
Long-term results of subtotal colectomy with cecorectal anastomosis for isolated colonic inertia. World J Gastroenterol (2007) 0.77
Primary versus delayed repair for bile duct injuries sustained during cholecystectomy: results of a survey of the Association Francaise de Chirurgie. HPB (Oxford) (2012) 0.77
Mapacalcine specifically blocks hypoxia-induced calcium influx in rat hepatocytes. Eur J Biochem (2003) 0.76
Laparoscopic sleeve gastrectomy: how I do it. Surg Laparosc Endosc Percutan Tech (2013) 0.75
Laparoscopic sleeve gastrectomy followed by duodenal switch in selected patients versus single-stage duodenal switch for superobesity: case-control study. Surg Obes Relat Dis (2012) 0.75
Comment on: Serial changes in inflammatory biomarkers after Roux-en-Y gastric bypass surgery. Surg Obes Relat Dis (2011) 0.75
Laparoscopic Roux-en-Y gastric bypass, but not rebanding, should be proposed as a rescue procedure for patients with failed laparoscopic gastric banding. Ann Surg (2005) 0.75
Chimerism in women with end stage renal diseases: Who's who? Chimerism (2012) 0.75
Positioning Trocars for Performing Sleeve Gastrectomy: the right side or between the legs of the patient? Obes Surg (2015) 0.75
Atrial natriuretic peptide (ANP) preconditioning: what is the relevance of the antiapoptotic effects? J Hepatol (2003) 0.75
Anti-apoptotic pro-survival effect of clotrimazole in a normothermic ischemia reperfusion injury animal model. J Surg Res (2010) 0.75
Single-incision laparoscopic cholecystectomy: is it more than a challenge? Surg Endosc (2011) 0.75
Laparoscopic conversion of vertical banded gastroplasty with an antireflux wrap into Roux-en-Y gastric bypass. Obes Surg (2007) 0.75
De Garengeot's Hernia: Radiological and Intraoperative Imaging. Am Surg (2016) 0.75
[Intestinal transplantation]. Gastroenterol Clin Biol (2007) 0.75
In situ intestinal ischemia-reperfusion injury in the pig: a model using the first jejunal artery for flushing. World J Surg (2007) 0.75
[Postoperative nursing after liver transplantation]. Soins (2008) 0.75